New drug aims to protect kidneys in patients with high uric acid
Disease control
Not yet recruiting
This study tests an experimental drug called ABP-671 in 80 adults with chronic kidney disease and high uric acid levels. Participants will receive either the drug or a placebo for 40 weeks to see if it reduces protein in the urine, a sign of kidney damage. The goal is to slow kid…
Phase: PHASE2 • Sponsor: Atom Therapeutics Co., Ltd • Aim: Disease control
Last updated May 17, 2026 11:51 UTC